Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes
Frej Fyhrquist(Helsinki University Hospital), Carol Forsblom(University of Helsinki), Per‐Henrik Groop(University of Helsinki), A. Tiitu(Minerva Foundation), O. Saijonmaa(Helsinki University Hospital)
Cited by 111
Related Papers
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|1.6k
The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
|Diabetes|2009|641
Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease
|Journal of the American Society of Nephrology|2013|578